https://orcid.org/0000-0003-0522-0320
References
- Savage MW, Dhatariya KK, Kilvert A, et al. Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis. Diabet Med. 2011;28(5):508–515.
- Sacks DB, Arnold M, Bakris GL, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2011;57(6):e1–e47.
- Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev. 1999;15(6):412–426.
- Møller N. Ketone body, 3-hydroxybutyrate: minor metabolite - major medical manifestations. J Clin Endocrinol Metab. 2020;1:105–109.
- Naunheim R, Jang TJ, Banet G, et al. Point-of-care test identifies diabetic ketoacidosis at triage. Acad Emerg Med. 2006;13(6):683–685.
- Harris S, Ng R, Syed H, et al. Near patient blood ketone measurements and their utility in predicting diabetic ketoacidosis. Diabet Med. 2005;22(2):221–224.
- Schwab TM, Hendey GW, Soliz TC. Screening for ketonemia in patients with diabetes. Ann Emerg Med. 1999;34(3):342–346.
- Taboulet P, Haas L, Porcher R, et al. Urinary acetoacetate or capillary beta-hydroxybutyrate for the diagnosis of ketoacidosis in the Emergency Department setting. Eur J Emerg Med. 2004;11(5):251–258.
- Arora S, Henderson SO, Long T, et al. Diagnostic accuracy of point-of-care testing for diabetic ketoacidosis at emergency-department triage: beta-hydroxybutyrate versus the urine dipstick . Diabetes Care. 2011;34(4):852–854.
- Arora S, Menchine M. The role of point-of-care β-hydroxybutyrate testing in the diagnosis of diabetic ketoacidosis: a review. Hosp Pract (1995). 2012;40(2):73–78.
- Dhatariya K. Blood ketones: measurement, interpretation, limitations, and utility in the management of diabetic ketoacidosis. Rev Diabet Stud. 2016;13(4):217–225.
- Klocker AA, Phelan H, Twigg SM, et al. Blood β-hydroxybutyrate vs. urine acetoacetate testing for the prevention and management of ketoacidosis in Type 1 diabetes: a systematic review. Diabet Med. 2013;30(7):818–824.
- Sumita NM, Ferreira CES, Martino MDV, et al. Clinical applications of point-of-care testing in different conditions. Clin Lab. 2018;64(7):1105–1112.
- Guimont MC, Desjobert H, Fonfrède M, et al. Multicentric evaluation of eight glucose and four ketone blood meters. Clin Biochem. 2015;48(18):1310–1316.
- Yu HY, Agus M, Kellogg MD. Clinical utility of Abbott Precision Xceed Pro® ketone meter in diabetic patients. Pediatr Diabetes. 2011;12(7):649–655.
- Helmersson-Karlqvist J, Höög Hammarström K, Palmberg K, et al. Evaluation of Nova StatStrip and FreeStyle Precision Pro blood ketone tests using 3-hydroxybutyrate doped samples. J Clin Lab Anal. 2019;33(4):e22851.
- Janssen MJ, Hendrickx BH, Habets-van der Poel CD, et al. Accuracy of the Precision® point-of-care ketone test examined by liquid chromatography tandem-mass spectrometry (LC-MS/MS) in the same fingerstick sample. Clin Chem Lab Med. 2010;48(12):1781–1784.
- CSLI. Measurement procedure comparison and bias estimation using patient samples; approved guideline - third edition. CSLI document EP09-A3. Wayne (PA): Clinical and Laboraotory Standards; 2013.
- Li PK, Lee JT, MacGillivray MH, et al. Direct, fixed-time kinetic assays for beta-hydroxybutyrate and acetoacetate with a centrifugal analyzer or a computer-backed spectrophotometer. Clin Chem. 1980;26(12):1713–1717.
- McMurray CH, Blanchflower WJ, Rice DA. Automated kinetic method for D-3-hydroxybutyrate in plasma or serum. Clin Chem. 1984;30(3):421–425.
- Armer J, Hunt N, Kaushal K, et al. Limitations to using point of care blood ketone testing to monitor treatment of diabetic ketoacidosis. Pract Diabet. 2013;30(9):380–382.
- Ceriotti F, Kaczmarek E, Guerra E, et al. Comparative performance assessment of point-of-care testing devices for measuring glucose and ketones at the patient bedside. J Diabetes Sci Technol. 2015;9(2):268–277.